System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 10, 2006, Pages 3389-3395

  Upadhya, Rajendra ^a   Zhang, Hong Shan ^a   Weiss, Louis M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; BENZIMIDAZOLE; FLUOROOROTIC ACID; FUMAGALONE; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; METHIONYL AMINOPEPTIDASE; METHIONYL AMINOPEPTIDASE 2; OVALICIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENCEPHALITOZOON CUNICULI; ENTEROCYTOZOON; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MICROSPORIDIOSIS; MICROSPORUM; MICROTUBULE ASSEMBLY; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; THROMBOCYTOPENIA;

AMINOPEPTIDASES; ANTIFUNGAL AGENTS; ENCEPHALITOZOON CUNICULI; ENZYME INHIBITORS; GENETIC ENGINEERING; HUMANS; METALLOENDOPEPTIDASES; MICROBIAL SENSITIVITY TESTS; SACCHAROMYCES CEREVISIAE;

EID: 33749536592     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00726-06     Document Type: Article

References (35)

1. Arfin, S. M., R. L. Kendall, L. Hall, L. H. Weaver, A. E. Stewart, B. W. Matthews, and R. A. Bradshaw. 1995. Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Proc. Natl. Acad. Sci. USA 92:7714-7718.
2. Brdlik, C. M., and C. M. Crews. 2004. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. J. Biol. Chem. 279:9475-9480.
3. Brophy, V. H., J. Vasquez, R. G. Nelson, J. R. Forney, A. Rosowsky, and C. H. Sibley. 2000. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 44:1019-1028.
4. Cali, A., P. M. Takvorian, S. Lewin, M. Rendel, C. S. Sian, M. Wittner, H. B. Tanowitz, E. Keohane, and L. M. Weiss. 1998. Brachiola vesicularum, n.g., n.sp., a new microsporidium associated with AIDS and myositis. J. Eukaryot. Microbiol. 45:240-251.
5. Corey, E. J., A. Guzman-Perez, and M. C. Noe. 1994. Short enantioselective synthesis of (-)-ovalicin, a potent inhibitor of angiogenesis, using substrate-enhanced catalytic asymmetric dihydroxylation. J. Am. Chem. Soc. 116:12109-12110.
6. Costa, S. F., and L. M. Weiss. 2000. Drug treatment of microsporidiosis. Drug Resist. Updates 3:384-399.
7. Coyle, C. M., L. M. Weiss, L. V. Rhodes III, A. Cali, P. M. Takvorian, D. F. Brown, G. S. Visvesvara, L. Xiao, J. Naktin, E. Young, M. Gareca, G. Colasante, and M. Wittner. 2004. Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N. Engl. J. Med. 351:42-47.
8. Deplazes, P., A. Mathis, and R. Weber. 2000. Epidemiology and zoonotic aspects of microsporidia of mammals and birds. Contrib. Microbiol. 6:236-260.
9. Didier, E. S. 2005. Microsporidiosis: an emerging and opportunistic infection in humans and animals. Acta Trop. 94:61-76.
10. Didier, E. S., L. B. Rogers, J. M. Orenstein, M. D. Baker, C. R. Vossbrinck, T. Van Gool, R. Hartskeerl, R. Soave, and L. M. Beaudet. 1996. Characterization of Encephalitozoon (Septata) intestinalis isolates cultured from nasal mucosa and bronchoalveolar lavage fluids of two AIDS patients. J. Eukaryot. Microbiol. 43:34-43.
11. Didier, E. S., J. A. Shadduck, P. J. Didier, N. Millichamp, and C. R. Vossbrinck. 1991. Studies on ocular microsporidia. J. Protozool. 38:635-638.
12. Dummitt, B., Y. Fei, and Y. H. Chang. 2002. Functional expression of human methionine aminopeptidase type 1 in Saccharomyces cerevisiae. Protein Pept. Lett. 9:295-303.
13. Gerum, A. B., J. E. Ulmer, D. P. Jacobus, N. P. Jensen, D. R. Sherman, and C. H. Sibley. 2002. Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase. Antimicrob. Agents Chemother. 46:3362-3369.
14. Gietz, D., A. St. Jean, R. A. Woods, and R. H. Schiestl. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20:1425.
15. Giglione, C., A. Boularot, and T. Meinnel. 2004. Protein N-terminal methionine excision. Cell. Mol. Life Sci. 61:1455-1474.
16. Giglione, C., A. Serero, M. Pierre, B. Boisson, and T. Meinnel. 2000. Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms. EMBO J. 19:5916-5929.
17. Griffith, E. C., Z. Su, B. E. Turk, S. Chen, Y. H. Chang, Z. Wu, K. Biemann, and J. O. Liu. 1997. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem. Biol. 4:461-471.
18. Ho, Y., A. Gruhler, A. Heilbut, G. D. Bader, L. Moore, S. L. Adams, A. Millar, P. Taylor, K. Bennett, K. Boutilier, L. Yang, C. Wolting, I. Donaldson, S. Schandorff, J. Shewnarane, M. Vo, J. Taggart, M. Goudreault, B. Muskat, C, Alfarano, D. Dewar, Z. Lin, K. Michalickova, A. R. Willems, H. Sassi, P. A. Nielsen, K. J. Rasmussen, J. R. Andersen, L. E. Johansen, L. H. Hansen, H. Jespersen, A. Podtelejnikov, E. Nielsen, J. Crawford, V. Poulsen, B. D. Sorensen, J. Matthiesen, R. C. Hendrickson, F. Gleeson, T. Pawson, M. F. Moran, D. Durocher, M. Mann, C. W. Hogue, D. Figeys, and M. Tyers. 2002. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415:180-183.
19. Katinka, M. D., S. Duprat, E. Cornillot, G. Metenier, F. Thomarat, G. Prensier, V. Barbe, E. Peyretaillade, P. Brottier, P. Wincker, F. Delbac, H. El Alaoui, P. Peyret, W. Saurin, M. Gouy, J. Weissenbach, and C. P. Vivares. 2001. Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi. Nature 414:450-453.
20. Knop, M., K. Siegers, G. Pereira, W. Zachariae, B. Winsor, K. Nasmyth, and E. Schiebel. 1999. Epitope tagging of yeast genes using a PCR-based strategy: more tags and improved practical routines. Yeast 15:963-972.
21. Kwon, J., H. W. Jeong, H. K. Kim, K. H. Kang, Y. H. Chang, K. S. Bae, et al. 2000. cis-Fumagillin, a new methionine amino peptidase (type 2) inhibitor produced by Penicillium sp. F2757. J. Antibiot. (Tokyo) 53:799-806.
22. Li, X., and Y. H. Chang. 1995. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proc. Natl. Acad. Sci. USA 92:12357-12361.
23. Masami Kusaka, K. S., T. Fujita, S. Marui, F. Itoh, D. Ingber, and J. Folkman. 1991. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem. Biophys. Res. Commun. 174:1070-1076.
24. Molina, J. M., M. Tourneur, C. Sarfati, S. Chevret, A. de Gouvello, J. G. Gobert, S. Balkan, and F. Derouin. 2002. Fumagillin treatment of intestinal microsporidiosis. N. Engl. J. Med. 346:1963-1969.
25. Peyret, P., M. D. Katinka, S. Duprat, F. Duffieux, V. Barbe, M. Barbazanges, J. Weissenbach, W. Saurin, and C. P. Vivares. 2001. Sequence and analysis of chromosome I of the amitochondriate intracellular parasite Encephalitozoon cuniculi (Microspora). Genome Res. 11:198-207.
26. Selvakumar, P., A. Lakshmikuttyamma, J. R. Dimmock, and R. K. Sharma. 2006. Methionine aminopeptidase 2 and cancer. Biochim. Biophys. Acta 1765:148-154.
27. Serero, A., C. Giglione, A. Sardini, J. Martinez-Sanz, and T. Meinnel. 2003. An unusual peptide deformylase features in the human mitochondrial N- terminal methionine excision pathway. J. Biol. Chem. 278:52953-52963.
28. Sibley, C. H., V. H. Brophy, S. Cheesman, K. L. Hamilton, E. G. Hankins, J. M. Wooden, and B. Kilbey. 1997. Yeast as a model system to study drugs effective against apicomplexan proteins. Methods 13:190-207.
29. Sin, N., L. Meng, M. Q. Wang, J. J. Wen, W. G. Bornmann, and C. M. Crews. 1997. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. USA 94:6099-6103.
30. Weber, R., P. Deplazes, M. Flepp, A. Mathis, R. Baumann, B. Sauer, H. Kuster, and R. Luthy. 1997. Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N. Engl. J. Med. 336:474-478.
31. Weber, R., P. Deplazes, and D. Schwartz. 2000. Diagnosis and clinical aspects of human microsporidiosis. Contrib. Microbiol. 6:166-192.
32. Weiss, L. M., S. F. Costa, and H. Zhang. 2001. Microsporidian methionine aminopeptidase type 2. J. Eukaryot. Microbiol. 48(Suppl.):88S-90S.
33. Wittner, M., and L. M. Weiss (ed.). 1999. The microsporidia and microsporidiosis. ASM Press, Washington, D.C.
34. Zhang, H., H. Huang, A. Cali, P. M. Takvorian, X. Feng, G. Zhou, and L. M. Weiss. 2005. Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. Folia Parasitol. (Prague) 52:182-192.
35. Zhou, G., C. W. Tsai, and J. O. Liu. 2003. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis. J. Med. Chem. 46:3452-3454.